NCT01746732View on ClinicalTrials.gov

A Study of Evacetrapib in Healthy Female Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

Ortho-Cyclen

Oral administration

DRUG

Evacetrapib

Oral administration

Trial Locations (1)

75247

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dallas

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01746732 - A Study of Evacetrapib in Healthy Female Participants | Biotech Hunter | Biotech Hunter